Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness
Open Access
- 30 November 2006
- journal article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 86 (5), 1483-1487
- https://doi.org/10.1016/j.fertnstert.2006.04.032
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptiveFertility and Sterility, 2006
- Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trialContraception, 2005
- Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancyHuman Reproduction Update, 2005
- Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive useContraception, 2004
- Regulation and Function of Inhibins in the Normal Menstrual CycleSeminars in Reproductive Medicine, 2004
- Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppressionAmerican Journal of Obstetrics and Gynecology, 2004
- Serum inhibin A, inhibin B, and pro-αC levels are altered after surgically or pharmacologically induced menopauseFertility and Sterility, 2002
- Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibitionFertility and Sterility, 2001
- Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal RingClinical Pharmacokinetics, 2000
- The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.Genes & Development, 1994